Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$192M |
| 2 |
Johnson & Johnson
JNJ
|
+$179M |
| 3 |
EMC
EMC CORPORATION
EMC
|
+$177M |
| 4 |
Chubb
CB
|
+$153M |
| 5 |
Eli Lilly
LLY
|
+$142M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$470M |
| 2 |
PRE
PARTNERRE LTD
PRE
|
+$186M |
| 3 |
Comcast
CMCSA
|
+$179M |
| 4 |
Pfizer
PFE
|
+$168M |
| 5 |
Gilead Sciences
GILD
|
+$144M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.85% |
| 2 | Technology | 12.31% |
| 3 | Financials | 12.27% |
| 4 | Industrials | 10.64% |
| 5 | Consumer Staples | 10.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Kopin
KOPN
$1B
| $1.18M | ﹤0.01% |
712,700
+196,779
| +38% | +$376K |
|
2502
Broadwind
BWEN
$125M
| $1.18M | ﹤0.01% |
391,900
+62,700
| +19% | +$135K |
|
|
VWTR
2503
DELISTED
Vidler Water Resouces, Inc. Common Stock
VWTR
| $1.18M | ﹤0.01% |
115,300
-13,800
| -11% | -$126K |
|
|
ENLK
2504
DELISTED
EnLink Midstream Partners, LP
ENLK
| $1.18M | ﹤0.01% |
+97,700
| New | +$1.07M |
|
|
MHG
2505
DELISTED
Marine Harvest ASA
MHG
| $1.17M | ﹤0.01% |
76,382
+25,982
| +52% | +$363K |
|
2506
Radiant Logistics
RLGT
$409M
| $1.17M | ﹤0.01% |
327,389
-66,388
| -17% | -$219K |
|
|
RBS.PRH.CL
2507
DELISTED
Royal Bank Of Scotland Group
RBS.PRH.CL
| $1.17M | ﹤0.01% |
45,300
+20,700
| +84% | +$526K |
|
|
TGB
2508
Trekor Metals
TGB
$3.1B
| $1.17M | ﹤0.01% |
2,067,900
+358,700
| +21% | +$144K |
|
|
NETI
2509
DELISTED
Eneti Inc.
NETI
| $1.16M | ﹤0.01% |
+38,102
| New | +$1.19M |
|
2510
CareTrust REIT
CTRE
$9.22B
| $1.16M | ﹤0.01% |
+91,200
| New | +$1.01M |
|
|
PPP
2511
DELISTED
Primero Mining Corp
PPP
| $1.16M | ﹤0.01% |
639,125
+416,812
| +187% | +$810K |
|
|
ASFI
2512
DELISTED
Asta Funding Inc
ASFI
| $1.16M | ﹤0.01% |
129,700
+3,400
| +3% | +$27K |
|
2513
Global Industrial
GIC
$1.48B
| $1.15M | ﹤0.01% |
131,600
+27,629
| +27% | +$232K |
|
|
NWLI
2514
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $1.15M | ﹤0.01% |
5,000
| – | – |
|
|
EPE
2515
DELISTED
EP Energy Corporation
EPE
| $1.15M | ﹤0.01% |
254,417
-190,214
| -43% | -$697K |
|
|
CYS
2516
DELISTED
CYS Investments Inc.
CYS
| $1.15M | ﹤0.01% |
+141,300
| New | +$1.04M |
|
|
FLXN
2517
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $1.15M | ﹤0.01% |
+124,500
| New | +$1.51M |
|
2518
Arbutus Biopharma
ABUS
$920M
| $1.14M | ﹤0.01% |
276,800
-79,200
| -22% | -$283K |
|
2519
Enova International
ENVA
$6.59B
| $1.14M | ﹤0.01% |
181,100
-79,500
| -31% | -$475K |
|
|
AXIA
2520
DELISTED
AXIA Energia
AXIA
| $1.14M | ﹤0.01% |
810,237
+244,233
| +43% | +$291K |
|
|
CAW
2521
DELISTED
CCA Industries, Inc.
CAW
| $1.14M | ﹤0.01% |
327,200
+2,700
| +0.8% | +$9.12K |
|
2522
Trupanion
TRUP
$1.35B
| $1.14M | ﹤0.01% |
115,600
+44,200
| +62% | +$396K |
|
2523
Inseego
INSG
$76.4M
| $1.14M | ﹤0.01% |
64,230
-16,470
| -20% | -$230K |
|
|
SKUL
2524
DELISTED
SKULLCANDY INC
SKUL
| $1.14M | ﹤0.01% |
319,390
+74,990
| +31% | +$270K |
|
2525
NRC Health Common Stock
NRC
$468M
| $1.13M | ﹤0.01% |
72,900
+11,600
| +19% | +$170K |
|
Similar funds
Jim Simons's Q1 2016 Portfolio in Review
As of Q1 2016, Jim Simons held 3,753 positions worth $52.6B, up 15% from $45.9B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $5.31B of net new capital in Q1 2016, opening 498 new positions and adding to 2,018 existing holdings. Its largest new stake was EMC CORPORATION: 7,000,400 shares worth $187M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 14% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Pfizer, an estimated $168M trimmed.
- Jim Simons's largest Q1 2016 buy was EMC CORPORATION: 7,000,400 shares worth $187M.
- Jim Simons added most to PepsiCo in Q1 2016, an estimated $192M increase.
- Jim Simons's biggest Q1 2016 reduction was Pfizer, cutting an estimated $168M.
- Jim Simons fully exited Apple in Q1 2016, selling an estimated $470M.
- Jim Simons's ten largest holdings make up 7.9% of its $52.6B portfolio in Q1 2016.
- Jim Simons opened 498 new positions and closed 403 in Q1 2016.
- Jim Simons's portfolio value rose 15% quarter-over-quarter to $52.6B.
Based on Renaissance Technologies's 13F filing for Q1 2016, filed 13 May 2016.